eQMS para ciencias de la vida 13 elementos
Combination Products cGMP Checklist (21 CFR Part 4)
Esta lista de verificación está en inglés.
Confirms that a drug-device or biologic-device combination product operates under a compliant streamlined cGMP approach integrating drug (211) and device (820) requirements. Use to audit combination product manufacturing.
21 CFR Part 421 CFR 21121 CFR 820
PDF o Word gratuito · introduzca su correo electrónico para descargar.
Constituent Parts and Approach
- Are the constituent parts of the combination product identified and classified (drug, device, biologic)? *
- Is a compliant cGMP operating model selected (drug or device base) with the streamlined approach documented? *
- Are the applicable base regulation requirements fully met (e.g., 21 CFR 211 for drug-led operations)? *
Called-Out Device Provisions
- Are the called-out device provisions implemented when operating under drug cGMP (design controls 820.30)? *
- Is purchasing control (820.50) applied to device constituent suppliers? *
- Are corrective and preventive action (820.100) requirements implemented? *
- Is installation (820.170) and servicing (820.200) applied where relevant?
Called-Out Drug Provisions
- When operating under device QMS, are the called-out drug provisions implemented (211.84 component testing, 211.166 stability)? *
- Is expiration dating (211.137) applied to drug constituents?
- Are reserve samples (211.170) maintained where required?
Integration and Reporting
- Are interactions between constituent parts assessed for safety and performance? *
- Are combination product adverse event and malfunction reporting requirements met? *
- Are labeling and human factors considerations addressed for the integrated product?
Descargue la lista de verificación Combination Products cGMP Checklist (21 CFR Part 4) completa
Obténgala gratis como PDF limpio e imprimible o como documento de Word editable.